Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Raul Prytog who wrote (10126)	5/20/1999 9:58:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Do you think XOMA was so impressed with Murphy's price targets that they put "TARGETS" on the cover and in their annual report? Does Murphy have that much influence with XOMA? Perhaps the P III trial took so long because Murphy moved his targets to 00-02, and the company did not want to get to the $45 target too soon. Totally agree with you that, Murphy, is a straight shooter and keeps his targets fixed in his sights rather than moving them all over the place. Seems logical to change the year the target will be reached rather than the target itself.